myBiometry

Based in the United States, myBiometry is a startup. Brouky classifies it under Healthcare & Life Sciences.

myBiometry develops a patented sensor and device that measures airway inflammation through fractional exhaled nitric oxide (FeNO) to predict and prevent asthma attacks by analyzing biological and environmental data via a mobile app.